Advances in Biopharmaceutical Technology in India

A Society for Industrial Microbiology and BioPlan Associates co-publication

Advances in Biopharmaceutical Technology in India can provide you the most up-to-date news and perspective on events and trends in this rapidly-changing biopharmaceutical industry. Whether you require basic information, or extensive support in partnering with the right companies in India, BioPlan will work with you to meet your needs.

Publication date: January 2008
BioPlan Associates, Inc. and Society for Industrial Microbiology
ISBN: 978-1-934106-07-5

Order Now

 

  1. Introduction: Biotechnology in India.
    • Dr. P. K. Ghosh President-Biotechnology, Cadila Pharmaceuticals Ltd
  2. A Window into India’s Biopharmaceutical Sector.
    • N. Kulkarni, Biospectrum Asia
  3. Indian Biopharmaceutical System and Policies.
    • Yennapu Madhavi, Ph. D, Scientist, National Institute of Science Technology and Development Studies
  4. Government Support for Biotech and Biopharmaceutical Industry.
    • Dr. B. M. Gandhi, CEO, Neo BioMed Services
  5. Biopharmaceutical Products in India.
    • Dr. Scott Wheelwright, Dr. Hazel Aranha, President, Strategic Manufacturing Worldwide, Inc.
  6. Biogeneric Manufacturing in India.
    • Dr. Ashesh Kumar, General Manager M J Biopharm Pvt. Ltd.
  7. Biopharmaceutical Market Situation.
    • Dr. Merlin Goldman President, Magnetical, U.K.
  8. Contract Research Industry in India.
    • Dr. Umakanta Sahoo & Dr. Faiz Kermani, Managing Director, Chiltern International Private Ltd.
  9. Regulatory Landscape for Clinical Trials in India.
    • Dr. Romi Singh, Executive Director, Global Regulatory Affairs, Amgen Inc.
  10. Life Sciences Education in India.
    • Dr. Dipti Sawant Dr. Umakanta Sahoo, Chiltern International Private Ltd.
  11. Vaccines Industry in India.
    1. Dr. PS Kulkarni Dr. SS Jadhav, Deputy Medical Director /Executive Director, Serum Institute of India Ltd.
  12. Development of plasma-derived biopharmaceuticals in India: Issues and Opportunities.
    • Dr. John Curling, President, John Curling, Consulting AB
  13. Bioprocess Technology in India.
    • Dr. David Mousdale, Managing Director Beocarta Ltd., U.K.
  14. Potential Applications of Recent Advances in Immunology to Develop Novel Therapeutic Products in India.
    • Dr. Kumar Shah, President, Endocrine Technology, LLC
  15. Early Stage Key R&D for Successful Development of Protein Products.
    • K. Madduri, Ph.D Dow AgroSciences LLC
  16. Understanding Ayurveda Medicine.
    • Dr. Sampada Mahajan, Chiltern International Private Ltd.
  17. Biopharmaceutical Outsourcing: A comparative Overview of the Landscape in India and China.
    • Minna Damani Editor, CanBiotech
  18. Biopharmaceutical Research Collaboration between Western and Indian Life Science Organizations.
    • Dr. Steve Ferguson, Director, Dr. Uri Reichman, Dr. Bharat Khurana, NIH Office of Technology Transfer
  19. Outsourcing R&D to India.
    • Sajai Singh, Probir Roy J. Sagar Associates
  20. Venture Capital Financing.
    • Sajai Singh Probir Roy Chodhur J. Sagar Associates
  21. Pre Clinical and Clinical Trial in India.
    • V.K.Srinivas, Ph.D, General Manager, R&D, Bharat Biotech International Limited
  22. Outsourcing Biopharma R&D to India.
    • Jim Schnabel, Senior Research Associate, BioPlan Associates, Inc.
  23. Technology Transfer: Impact and Importance for Indian Biotechnology Growth.
    • Susan Kling Finston, Founder and Principal, Finston Consulting, LLC
Scroll to Top